SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950137-03-005185
Filing Date
2003-10-15
Accepted
2003-10-15 17:13:21
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM S-3 c80089sv3.txt S-3 82858
3 OPINION/CONSENT OF KATTEN MUCHIN ZAVIS ROSENMAN c80089exv5w1.txt EX-5.1 3702
4 CONSENT OF ERNST & YOUNG LLP c80089exv23w1.txt EX-23.1 788
  Complete submission text file 0000950137-03-005185.txt   89276
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-109724 | Film No.: 03942335
SIC: 2834 Pharmaceutical Preparations